Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 2/20 | 0.35 |
| ▸ | CNR2 | P34972 | 2/20 | 0.33 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 5/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21925692 | 0.83 | ALDH1A1 (0.38) | TGFBR1CNR2KCNK3ALDH1A1THRB | |
| SCHEMBL4338104 | 0.83 | ALDH1A1 (0.38) | TGFBR1CNR2KCNK3ALDH1A1THRB | |
| SCHEMBL9193899 | 0.77 | TGFBR1 (0.59) | TGFBR1CNR2KCNK3ALDH1A1THRB | |
| SCHEMBL48911 | 0.75 | — | — | |
| SCHEMBL982687 | 0.75 | — | — | |
| SCHEMBL48766 | 0.75 | — | — | |
| SCHEMBL20087845 | 0.75 | CA12 (0.39) | ALDH1A1 | |
| SCHEMBL15087111 | 0.73 | ALDH1A1 (0.33) | TGFBR1CNR2KCNK3ALDH1A1THRB | |
| SCHEMBL21573850 | 0.71 | TSHR (0.31) | — | |
| SCHEMBL1231366 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11712404-B2 | Methacrylamide adhesive systems | UNIV OREGON HEALTH & SCIENCE (US) | 2023-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11712404-B2 | Methacrylamide adhesive systems | ECPAS, CAD, ILK | TGFBR1 2475/4885CNR2 4842/4885KCNK3 4382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.